Insider Transactions in Q2 2022 at Oscar Health, Inc. (OSCR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2022
|
Jeffery H Boyd |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
|
Jun 09
2022
|
Vanessa Ames Wittman |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
|
Jun 09
2022
|
Jr Charles E Phillips |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
|
Jun 09
2022
|
David Plouffe |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
|
Jun 09
2022
|
Elbert O. Robinson Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
35,787
+29.44%
|
-
|
|
Jun 06
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
19,546
-6.89%
|
$97,730
$5.01 P/Share
|
|
Jun 06
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
11,300
-7.94%
|
$56,500
$5.01 P/Share
|
|
Jun 05
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+18.05%
|
-
|
|
Jun 05
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+18.0%
|
-
|
|
Jun 02
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
SELL
Open market or private sale
|
Direct |
2,556
-2.25%
|
$10,224
$4.69 P/Share
|
|
Jun 02
2022
|
Richard Scott Blackley Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,135
-0.96%
|
$8,540
$4.69 P/Share
|
|
Jun 02
2022
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
1,548
-7.92%
|
$6,192
$4.69 P/Share
|
|
Jun 02
2022
|
Victoria Baltrus Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,222
-29.66%
|
$4,888
$4.69 P/Share
|
|
Jun 02
2022
|
Ranmali Bopitiya EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,961
-29.19%
|
$23,844
$4.69 P/Share
|
|
Jun 01
2022
|
Alessandrea C. Quane EVP, Chief Insurance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+5.82%
|
-
|
|
Jun 01
2022
|
Richard Scott Blackley Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,016
+3.04%
|
-
|
|
Jun 01
2022
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,171
+14.56%
|
-
|
|
Jun 01
2022
|
Victoria Baltrus Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,120
+50.0%
|
-
|
|
Jun 01
2022
|
Ranmali Bopitiya EVP & Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,424
+50.0%
|
-
|